MEI Pharma Balance Sheet Health
Financial Health criteria checks 4/6
MEI Pharma has a total shareholder equity of $24.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $27.8M and $2.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$26.91m |
| Equity | US$24.88m |
| Total liabilities | US$2.87m |
| Total assets | US$27.75m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0JW9's short term assets ($27.7M) exceed its short term liabilities ($2.9M).
Long Term Liabilities: 0JW9 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 0JW9 is debt free.
Reducing Debt: 0JW9 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0JW9 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0JW9 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.9% each year